Be Prepared if Your Infusion Center Gives Romosozumab (Evenity) for Osteoporosis
September 2019
You'll see some postmenopausal women admitted on the new osteoporosis med romosozumab (Evenity, ee-VEN-ih-tee).
Romosozumab is an injectable monoclonal antibody that blocks sclerostin, a protein involved in bone metabolism. This leads to increased bone growth AND decreased bone breakdown.
Other osteoporosis meds do one or the other.
Get concise advice on drug therapy, plus unlimited access to CE
Hospital Pharmacist's Letter membership benefits include:
- 12 issues every year — what you need to know and do, right now
- Quick, practical reference charts and tools
- Comprehensive CE library to meet license renewal and state requirements
- Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
- Plus much more!
Choose the right tier for your needs today.
Already a subscriber? Log in
Volume pricing available. Get a quote